Related Experiment Video
Updated: May 9, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Migraine genetics--a review: Part I
Stephen D Silberstein1, David W Dodick
1Thomas Jefferson University, Philadelphia, PA, USA.
Headache
|July 16, 2013
Summary
Molecular genetics offers new insights into migraine causes. Understanding these genetic advances is crucial for clinicians to improve patient care and develop novel migraine treatments.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Migraine is a complex neurological disorder with a significant genetic component.
- Advances in molecular genetics are revolutionizing our understanding of disease pathogenesis.
- Clinicians require foundational knowledge of genetics for critical literature appraisal.
Purpose of the Study:
- To provide a primer on the fundamentals of molecular genetics.
- To highlight recent advances in molecular genetics relevant to migraine.
- To establish a basis for understanding the genetic basis of migraine.
Main Methods:
- This paper focuses on foundational concepts in molecular genetics.
- It serves as an introduction to a forthcoming paper detailing genetic advances in migraine.
- Methodologies like genome-wide association studies will be discussed in the companion paper.
Main Results:
- Molecular genetics provides unprecedented insights into migraine pathogenesis.
- Understanding genetic factors aids in identifying potential therapeutic targets.
- This foundational knowledge supports the critical appraisal of scientific literature.
Conclusions:
- A grasp of molecular genetics is essential for advancing migraine research and treatment.
- Future drug development for migraine can be informed by genetic discoveries.
- This primer sets the stage for exploring specific genetic advances in migraine management.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...